4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Annexon, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) ANX005 - Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase 2 | Completed | Annexon, Inc. | 7 | 2021-11-10 | 2026-06-30 |
| A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy ANX007, Sham comparator - Geographic Atrophy | Phase 2 | Completed | Annexon, Inc. | 270 | 2021-02-26 | 2026-10-21 |
| Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS) ANX005 - Amyotrophic Lateral Sclerosis | Phase 2 | Completed | Annexon, Inc. | 17 | 2021-01-15 | 2025-01-06 |
| An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's Disease ANX005 - Huntington Disease | Phase 2 | Completed | Annexon, Inc. | 28 | 2020-09-29 | 2026-08-25 |
Amyotrophic Lateral Sclerosis (1) · Geographic Atrophy (1) · Huntington Disease (1)
United States (4) · Australia (2) · Austria (1) · Bulgaria (1) · Canada (1) · New Zealand (1)
Benjamin Hoehn, MD (1) · Benjamin Hoehn, MD, PhD (1)